Development of LC-MS/MS-Based Receptor Occupancy Tracers and Positron Emission Tomography Radioligands for the Nociceptin/Orphanin FQ (NOP) Receptor

详细信息    查看全文

• 作者：Concepci贸n Pedregal ; Elizabeth M. Joshi ; Miguel A. Toledo ; Celia Lafuente ; Nuria Diaz ; Maria A. Martinez-Grau ; Alma Jim茅nez ; Ana Benito ; Antonio Navarro ; Zhaogen Chen ; Daniel R. Mudra ; Steven D. Kahl ; Karen S. Rash ; Michael A. Statnick ; Vanessa N. Barth
• 刊名：Journal of Medicinal Chemistry
• 出版年：2012
• 出版时间：June 14, 2012
• 年：2012
• 卷：55
• 期：11
• 页码：4955-4967
• 全文大小：478K
• 年卷期：v.55,no.11(June 14, 2012)
• ISSN：1520-4804

文摘

Currently, a lack of sufficient tools has limited the understanding of the relationship between neuropsychiatric disorders and the nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor. Herein, we describe the discovery and development of an antagonist NOP receptor occupancy (RO) tracer and a novel positron emission tomography (PET) radioligand suitable to probe the NOP receptor in human clinical studies. A thorough structure鈥揳ctivity relationship (SAR) around the high-affinity 3-(2鈥?fluoro-4鈥?5鈥?dihydrospiro[piperidine-4,7鈥?thieno[2,3-c]pyran]-1-yl)-2-(2-halobenzyl)-N-alkylpropanamide scaffold identified a series of subnanomolar, highly selective NOP antagonists. Subsequently, these unlabeled NOP ligands were evaluated in vivo by liquid chromatography-tandem mass spectrometry (LC-MS/MS) in rat to determine brain uptake, kinetics and specific binding. (S)-27 was identified as a suitable unlabeled preclinical RO tracer to accurately quantify NOP receptor engagement in rat brain. Three compounds were selected for evaluation in nonhuman primates as PET tracers: (鈭?-26, (鈭?-30, and (鈭?-33. Carbon-11 labeling of (+)-31 yielded [¹¹C]-(S)-30, which exhibited minimal generation of central nervous system (CNS) penetrant radiometabolites, improved brain uptake, and was an excellent PET radioligand in both rat and monkey. Currently [¹¹C]-(S)-30 is being evaluated as a PET radiotracer for the NOP receptor in human subjects.